SecBot SecBot
8-K ·Filed Oct 16, 2026

OCUL

OCULAR THERAPEUTIX, INC
NEUTRAL
Impact 2/10
Horizondays Processed11d 13h ago SEC0001104659-26-116617
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

Monitor for any subsequent announcement of a replacement Chief Strategy Officer or restructuring of the strategy function. This single departure is unlikely to affect operations near-term.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled: T+5d
OCUL ▲ +2.86% at T+5d
NEUTRAL call +2.86% · α vs SPY +3.01% · entry $6.29 → $6.47
Next anchor: T+20d in 16d
Latest observation: T+6 -0.27% FF3 residual α
Entry = T+0 close
Oct 16, 2026
via day close
T+1d
+5.72%
call +5.72% · α +5.39%
$6.65
settled 9d ago
T+5d
+2.86%
call +2.86% · α +3.01%
$6.47
settled 5d ago
T+20d
Pending
in 16d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

Chief Strategy Officer Sanjay Nayak resigned effective October 16, 2026 to become CEO of a private company. The departure is voluntary and for a career opportunity, with no red flags such as termination or lack of replacement. This is a routine C-suite departure at a non-CEO level.

Key Facts

  • Sanjay Nayak (Chief Strategy Officer) resigned on October 14, 2026, effective October 16, 2026
  • Reason for departure: to become CEO of a privately-held company
  • No replacement named in the filing
  • CFO Jason S. Robins signed the filing

Financial Impact

No financial impact disclosed; routine officer departure with no severance or material compensation details provided

Risk Factors

  • Loss of strategic leadership could slow pipeline or partnership initiatives if not backfilled promptly

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001104659-26-116617
Document: 0001104659-26-116617-index-headers.html0001104659-26-116617
Document: 0001104659-26-116617-index.html0001104659-26-116617
Document: 0001104659-26-116617.txt0001104659-26-116617
16 reports for OCUL
Performance horizon
75% Hit rate @ T+60 3 of 4 directional calls Went positive at some point 4 of 4 best @ T+20▲ +24.88%Aug 3, 2026
Filters
Rows
Reports for OCUL, sortable and filterable
TypeNow
Oct 16, 2026
11d ago
8-K
NEUTRAL ★ 2/10
$6.29awaiting T+60awaiting T+60$6.72 (+6.84%)
Oct 8, 2026
19d ago
144
NEUTRAL ★ 2/10
$7.54awaiting T+60awaiting T+60$6.72 (−10.88%)
Sep 2, 2026
7w ago
Insider Cluster
NEUTRAL ★ 4/10
$10.64awaiting T+60awaiting T+60$6.72 (−36.84%)
Aug 26, 2026
8w ago
Insider Cluster
NEUTRAL ★ 3/10
$10.82awaiting T+60awaiting T+60$6.72 (−37.89%)
Aug 3, 2026
12w ago
8-K
BULLISH ★ 7/10
$8.40 $6.61▼ −21.31%▼ −23.09%$6.72 (−20.00%)
Jun 17, 2026
18w ago
Press Release
BULLISH ★ 6/10
$9.64 $10.49▲ +8.82%▲ +5.67%$6.72 (−30.29%)
Jun 12, 2026
19w ago
8-K
NEUTRAL ★ 3/10
$8.99 $11.47▲ +27.59%▲ +26.58%$6.72 (−25.25%)
Jun 4, 2026
20w ago
Press Release
BULLISH ★ 7/10
$8.80 $10.36▲ +17.73%▲ +15.85%$6.72 (−23.64%)
May 28, 2026
21w ago
Insider Cluster
NEUTRAL ★ 3/10
$9.01 $10.78▲ +19.64%▲ +18.46%$6.72 (−25.42%)
May 5, 2026
25w ago
8-K
NEUTRAL ★ 5/10
$9.71 $8.47▼ −12.77%▼ −15.51%$6.72 (−30.79%)
Showing 10 of 16

US Market Status

Market Closed · Opens in 4h 15m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 16, 2026